Abstract:To identify host factors that influence SARS-coronavirus (SARS-CoV) replication, we performed an siRNA library screen targeting the human kinome. Protein kinases are key regulators of many cellular functions and the systematic knockdown of their expression should provide a broad perspective on factors and pathways promoting or antagonizing coronavirus replication. In addition to 40 proviral proteins that promote SARS-CoV replication, our study identified 90 factors with an antiviral effect. Pathway analysis grouped subsets of these factors in specific cellular pathways, like the innate immune response and the metabolism of complex lipids, which thus appear to play an important role in SARS-CoV-infected cells. Two factors were selected for more extensive validation and follow-up experiments. In cells depleted for the beta 2 subunit of the coatomer protein complex (COPB2), the strongest proviral hit, we observed reduced SARS-CoV protein expression and a 2-log reduction in virus yield. The effect of knockdown of the COPB2-related factors COPB1 and Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 (GBF1) also suggested that COPI-coated vesicles and/or the early secretory pathway are important for SARS-CoV replication. Depletion of the antiviral double-stranded RNA-activated protein kinase (PKR) enhanced virus replication, and validation experiments using PKR-directed siRNAs confirmed increased SARS-CoV protein expression and virus production upon PKR depletion. The inventory of proand antiviral host factors and pathways described in this study expands our understanding of the replication of SARS-CoV, and may contribute to the identification of novel targets for antiviral therapy. Host factors in SARS-CoV replication 89 CH A PT ER 5 INTRODUCTION Positive-stranded RNA (+RNA) viruses interact with the infected host cell at many levels during their replicative cycle, and thus far numerous host cell proteins with a role in virus replication have been identified [60-65]. These include on the one hand host factors that are used by the virus during the various stages of its life cycle, and on the other hand factors that are part of the host defense against virus infection. Such proteins may constitute interesting targets in the development of novel antiviral strategies, as drug resistance is less likely to develop when cellular rather than viral functions are targeted. Antiviral drug resistance is a serious problem, in particular when combating RNA viruses, due to their high mutation rate and potential for rapid adaptation. Systems biology approaches have been instrumental in advancing our knowledge of individual proteins and cellular pathways that influence +RNA virus infection. For example, systematic functional genomics screens using small interfering RNA (siRNA) libraries have identified numerous host genes with a role in the replication of important human pathogens like West Nile virus [334], Dengue virus [335], human immunodeficiency virus 1 [336], hepatitis C virus [337-342], and influenza virus [338, 343, 344]. For coronaviruses a number of relevant host proteins were previously described ([321], and reviewed in [65, 320]), but the use of larger-scale siRNA screens to systematically identify such factors was not documented thus far. Coronaviruses, and other members of the order Nidovirales [286], have the largest RNA genomes known to date (27-31 kb [37]) and the complexity of their molecular biology clearly distinguishes them from other +RNA virus groups. Although infection with most human coronaviruses is associated with relatively mild respiratory disease [19, 345], the 2003 outbreak of severe acute respiratory syndrome (SARS) highlighted the potential of coronaviruses to cause lethal disease in humans. The zoonotic transfer of SARS-coronavirus (SARS-CoV), which likely originated from bats, initiated an outbreak that affected about 8,000 humans, with a mortality of about 10% [317]. Strikingly, a similar outbreak of coronavirus-induced severe respiratory disease has been developing in a number of Arab countries since April 2012, with 9 of the 15 confirmed cases thus far (March 2013) having a fatal outcome (http://www.who.int/csr/don/archive/disease/ coronavirus_infections/en/). The causative agent, human coronavirus EMC/2012, was recently identified as a previously unknown member of betacoronavirus subgroup 2c [15, 16]. Although the source of this emerging human pathogen remains to be identified, it is striking that – as in the case of SARS-CoV its closest known relatives are coronaviruses circulating in bats [16]. These recent developments highlight once again the relevance of the systematic dissection of coronavirus-host interactions and the development of antiviral approaches to combat coronavirus infection.

SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis

Interactome Analysis of the Nucleocapsid Protein of SARS-CoV-2 Virus

Host protein kinases required for SARS-CoV-2 nucleocapsid phosphorylation and viral replication

A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins

Host Cell Cycle Checkpoint As Antiviral Target for SARS-CoV-2 Revealed by Integrative Transcriptome and Proteome Analyses

RNA‐dependent RNA polymerase of SARS‐CoV‐2 as a therapeutic target

Global siRNA Screen Reveals Critical Human Host Factors of SARS-CoV-2 Multicycle Replication

A kinome-wide siRNA screen identifies proviral and antiviral host factors in SARS-coronavirus replication, including PKR and early secretory pathway proteins

Viral and Host Transcriptomes in SARS-CoV-2-Infected Human Lung Cells

SARS-CoV-2 promotes RIPK1 activation to facilitate viral propagation

SARS‐CoV‐2 infection activates CREB/CBP in cellular cyclic AMP‐dependent pathways

SARS‐CoV‐2 NSP12 utilizes various host splicing factors for replication and splicing regulation

A New Cellular Interactome of SARS-CoV-2 Nucleocapsid Protein and Its Biological Implications

Conserved Genomic Terminals of SARS-CoV-2 as Coevolving Functional Elements and Potential Therapeutic Targets

The SARS-CoV-2 RNA polymerase is a viral RNA capping enzyme

SARS-CoV-2 Nsp5 Demonstrates Two Distinct Mechanisms Targeting RIG-I and MAVS To Evade the Innate Immune Response

Identification of Cellular Factors Required for SARS-CoV-2 Replication

SARS-CoV-2 Nsp1 cooperates with initiation factors EIF1 and 1A to selectively enhance translation of viral RNA

SARS CoV 2 RNA dependent RNA polymerase in complex with cofactors in reduced condition

Discovery and Functional Interrogation of the Virus and Host RNA Interactome of SARS-Cov-2 Proteins

SARS-CoV-2 exploits host DGAT and ADRP for efficient replication